Endometrial 0.54

Endometrial thickness of 0.54 cm is considered thin, which may affect pregnancy or indicate endocrine abnormalities. Endometrial thickness is affected by the menstrual cycle, hormone levels and pathological factors, and needs to be comprehensively evaluated in conjunction with clinical manifestations.

Endometrial thickness changes dynamically during the menstrual cycle. During the proliferative phase, the endometrium gradually thickens under the influence of estrogen, and the thickness usually varies within the range of 0.5-1.0 cm. During the secretory phase, the endometrium further thickens to 1.0-1.5 cm under the action of progesterone to prepare for implantation of the fertilized egg. A measurement value of 0.54 cm is considered a normal physiological phenomenon if it appears in the early stage of proliferation, but if it remains at this level during the secretory phase, it indicates dysplasia. Long-term use of short-acting contraceptive pills may inhibit endometrial hyperplasia, and a history of uterine cavity operations such as induced abortion may cause damage to the basal layer. These factors may cause the endometrium to be thin. In patients with polycystic ovary syndrome, progesterone deficiency due to ovulatory disorders can also affect endometrial transformation.

Pathologically thin endometrium requires vigilance for the possibility of intrauterine adhesions. Repeated uterine cavity operations or infections may cause fibrous tissue hyperplasia and form adhesions to limit endometrial growth. When ultrasonography shows interruption of endometrial continuity or local echo enhancement, further hysteroscopy is required for diagnosis. Endometrial tuberculosis infection can destroy the functional layer of the endometrium, accompanied by symptoms of sharp decrease in menstrual flow or even amenorrhea. Autoimmune diseases such as antiphospholipid antibody syndrome may affect intimal blood perfusion, leading to refractory thin intima. For those with fertility needs, estrogen supplementation therapy can be considered to promote intimal hyperplasia, combined with drugs to improve microcirculation such as aspirin enteric-coated tablets. Patients with intrauterine adhesions need to undergo hysteroscopic adhesion separation, and a balloon stent should be placed after surgery to prevent re-adhesion.

It is recommended to review vaginal ultrasound on days 10-12 of the menstrual cycle to dynamically observe changes in the endometrium. Women preparing for pregnancy can monitor their basal body temperature combined with ovulation test strips to determine the synchrony of endometrium thickness and ovulation. Avoid excessive dieting to lose weight and ensure high-quality protein intake to help repair the endometrium. Phytoestrogen foods such as soybeans and flax seeds can be supplemented in moderation, but they cannot replace drug treatment. When there is a significant decrease in menstrual flow or cycle disorders, you should seek medical treatment as soon as possible to rule out organic diseases.